Global Autologous Cell Therapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 91 pages | ID: G0AF25B27C6EN
LP Information

Abstracts

According to this study, the global Autologous Cell Therapy market size will reach US$ 20960 million by 2031.

Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.

United States market for Autologous Cell Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Autologous Cell Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Autologous Cell Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Autologous Cell Therapy players cover BioTime, Pharmicell, BrainStorm Cell Therapeutics, Opexa Therapeutics, Vericel Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Autologous Cell Therapy Industry Forecast” looks at past sales and reviews total world Autologous Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Autologous Cell Therapy sales for 2025 through 2031. With Autologous Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autologous Cell Therapy industry.

This Insight Report provides a comprehensive analysis of the global Autologous Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Autologous Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autologous Cell Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autologous Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autologous Cell Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Autologous Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Bone Marrow
• Epidermis

Segmentation by Application:

• Neurology
• Orthopedics
• Cancer
• Wound Healing
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• BioTime
• Pharmicell
• BrainStorm Cell Therapeutics
• Opexa Therapeutics
• Vericel Corporation
• Regeneus

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Autologous Cell Therapy Market Size (2020-2031)
  2.1.2 Autologous Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Autologous Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 Autologous Cell Therapy Segment by Type
  2.2.1 Bone Marrow
  2.2.2 Epidermis
2.3 Autologous Cell Therapy Market Size by Type
  2.3.1 Autologous Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Autologous Cell Therapy Market Size Market Share by Type (2020-2025)
2.4 Autologous Cell Therapy Segment by Application
  2.4.1 Neurology
  2.4.2 Orthopedics
  2.4.3 Cancer
  2.4.4 Wound Healing
  2.4.5 Others
2.5 Autologous Cell Therapy Market Size by Application
  2.5.1 Autologous Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Autologous Cell Therapy Market Size Market Share by Application (2020-2025)

3 AUTOLOGOUS CELL THERAPY MARKET SIZE BY PLAYER

3.1 Autologous Cell Therapy Market Size Market Share by Player
  3.1.1 Global Autologous Cell Therapy Revenue by Player (2020-2025)
  3.1.2 Global Autologous Cell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Autologous Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 AUTOLOGOUS CELL THERAPY BY REGION

4.1 Autologous Cell Therapy Market Size by Region (2020-2025)
4.2 Global Autologous Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Autologous Cell Therapy Market Size Growth (2020-2025)
4.4 APAC Autologous Cell Therapy Market Size Growth (2020-2025)
4.5 Europe Autologous Cell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Autologous Cell Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Autologous Cell Therapy Market Size by Country (2020-2025)
5.2 Americas Autologous Cell Therapy Market Size by Type (2020-2025)
5.3 Americas Autologous Cell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Autologous Cell Therapy Market Size by Region (2020-2025)
6.2 APAC Autologous Cell Therapy Market Size by Type (2020-2025)
6.3 APAC Autologous Cell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Autologous Cell Therapy Market Size by Country (2020-2025)
7.2 Europe Autologous Cell Therapy Market Size by Type (2020-2025)
7.3 Europe Autologous Cell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Autologous Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa Autologous Cell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Autologous Cell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL AUTOLOGOUS CELL THERAPY MARKET FORECAST

10.1 Global Autologous Cell Therapy Forecast by Region (2026-2031)
  10.1.1 Global Autologous Cell Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Autologous Cell Therapy Forecast
  10.1.3 APAC Autologous Cell Therapy Forecast
  10.1.4 Europe Autologous Cell Therapy Forecast
  10.1.5 Middle East & Africa Autologous Cell Therapy Forecast
10.2 Americas Autologous Cell Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Autologous Cell Therapy Forecast
  10.2.2 Canada Market Autologous Cell Therapy Forecast
  10.2.3 Mexico Market Autologous Cell Therapy Forecast
  10.2.4 Brazil Market Autologous Cell Therapy Forecast
10.3 APAC Autologous Cell Therapy Forecast by Region (2026-2031)
  10.3.1 China Autologous Cell Therapy Market Forecast
  10.3.2 Japan Market Autologous Cell Therapy Forecast
  10.3.3 Korea Market Autologous Cell Therapy Forecast
  10.3.4 Southeast Asia Market Autologous Cell Therapy Forecast
  10.3.5 India Market Autologous Cell Therapy Forecast
  10.3.6 Australia Market Autologous Cell Therapy Forecast
10.4 Europe Autologous Cell Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Autologous Cell Therapy Forecast
  10.4.2 France Market Autologous Cell Therapy Forecast
  10.4.3 UK Market Autologous Cell Therapy Forecast
  10.4.4 Italy Market Autologous Cell Therapy Forecast
  10.4.5 Russia Market Autologous Cell Therapy Forecast
10.5 Middle East & Africa Autologous Cell Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Autologous Cell Therapy Forecast
  10.5.2 South Africa Market Autologous Cell Therapy Forecast
  10.5.3 Israel Market Autologous Cell Therapy Forecast
  10.5.4 Turkey Market Autologous Cell Therapy Forecast
10.6 Global Autologous Cell Therapy Forecast by Type (2026-2031)
10.7 Global Autologous Cell Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Autologous Cell Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 BioTime
  11.1.1 BioTime Company Information
  11.1.2 BioTime Autologous Cell Therapy Product Offered
  11.1.3 BioTime Autologous Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 BioTime Main Business Overview
  11.1.5 BioTime Latest Developments
11.2 Pharmicell
  11.2.1 Pharmicell Company Information
  11.2.2 Pharmicell Autologous Cell Therapy Product Offered
  11.2.3 Pharmicell Autologous Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Pharmicell Main Business Overview
  11.2.5 Pharmicell Latest Developments
11.3 BrainStorm Cell Therapeutics
  11.3.1 BrainStorm Cell Therapeutics Company Information
  11.3.2 BrainStorm Cell Therapeutics Autologous Cell Therapy Product Offered
  11.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 BrainStorm Cell Therapeutics Main Business Overview
  11.3.5 BrainStorm Cell Therapeutics Latest Developments
11.4 Opexa Therapeutics
  11.4.1 Opexa Therapeutics Company Information
  11.4.2 Opexa Therapeutics Autologous Cell Therapy Product Offered
  11.4.3 Opexa Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Opexa Therapeutics Main Business Overview
  11.4.5 Opexa Therapeutics Latest Developments
11.5 Vericel Corporation
  11.5.1 Vericel Corporation Company Information
  11.5.2 Vericel Corporation Autologous Cell Therapy Product Offered
  11.5.3 Vericel Corporation Autologous Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Vericel Corporation Main Business Overview
  11.5.5 Vericel Corporation Latest Developments
11.6 Regeneus
  11.6.1 Regeneus Company Information
  11.6.2 Regeneus Autologous Cell Therapy Product Offered
  11.6.3 Regeneus Autologous Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Regeneus Main Business Overview
  11.6.5 Regeneus Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Autologous Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Autologous Cell Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Bone Marrow
Table 4. Major Players of Epidermis
Table 5. Autologous Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Autologous Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Autologous Cell Therapy Market Size Market Share by Type (2020-2025)
Table 8. Autologous Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Autologous Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Autologous Cell Therapy Market Size Market Share by Application (2020-2025)
Table 11. Global Autologous Cell Therapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Autologous Cell Therapy Revenue Market Share by Player (2020-2025)
Table 13. Autologous Cell Therapy Key Players Head office and Products Offered
Table 14. Autologous Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Autologous Cell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Autologous Cell Therapy Market Size Market Share by Region (2020-2025)
Table 19. Global Autologous Cell Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Autologous Cell Therapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Autologous Cell Therapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Autologous Cell Therapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Autologous Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Autologous Cell Therapy Market Size Market Share by Type (2020-2025)
Table 25. Americas Autologous Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Autologous Cell Therapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Autologous Cell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Autologous Cell Therapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Autologous Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Autologous Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Autologous Cell Therapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Autologous Cell Therapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Autologous Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Autologous Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Autologous Cell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Autologous Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Autologous Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Autologous Cell Therapy
Table 39. Key Market Challenges & Risks of Autologous Cell Therapy
Table 40. Key Industry Trends of Autologous Cell Therapy
Table 41. Global Autologous Cell Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Autologous Cell Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Autologous Cell Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Autologous Cell Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. BioTime Details, Company Type, Autologous Cell Therapy Area Served and Its Competitors
Table 46. BioTime Autologous Cell Therapy Product Offered
Table 47. BioTime Autologous Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. BioTime Main Business
Table 49. BioTime Latest Developments
Table 50. Pharmicell Details, Company Type, Autologous Cell Therapy Area Served and Its Competitors
Table 51. Pharmicell Autologous Cell Therapy Product Offered
Table 52. Pharmicell Autologous Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Pharmicell Main Business
Table 54. Pharmicell Latest Developments
Table 55. BrainStorm Cell Therapeutics Details, Company Type, Autologous Cell Therapy Area Served and Its Competitors
Table 56. BrainStorm Cell Therapeutics Autologous Cell Therapy Product Offered
Table 57. BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. BrainStorm Cell Therapeutics Main Business
Table 59. BrainStorm Cell Therapeutics Latest Developments
Table 60. Opexa Therapeutics Details, Company Type, Autologous Cell Therapy Area Served and Its Competitors
Table 61. Opexa Therapeutics Autologous Cell Therapy Product Offered
Table 62. Opexa Therapeutics Autologous Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Opexa Therapeutics Main Business
Table 64. Opexa Therapeutics Latest Developments
Table 65. Vericel Corporation Details, Company Type, Autologous Cell Therapy Area Served and Its Competitors
Table 66. Vericel Corporation Autologous Cell Therapy Product Offered
Table 67. Vericel Corporation Autologous Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Vericel Corporation Main Business
Table 69. Vericel Corporation Latest Developments
Table 70. Regeneus Details, Company Type, Autologous Cell Therapy Area Served and Its Competitors
Table 71. Regeneus Autologous Cell Therapy Product Offered
Table 72. Regeneus Autologous Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Regeneus Main Business
Table 74. Regeneus Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Autologous Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Autologous Cell Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Autologous Cell Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Autologous Cell Therapy Sales Market Share by Country/Region (2024)
Figure 8. Autologous Cell Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Autologous Cell Therapy Market Size Market Share by Type in 2024
Figure 10. Autologous Cell Therapy in Neurology
Figure 11. Global Autologous Cell Therapy Market: Neurology (2020-2025) & ($ millions)
Figure 12. Autologous Cell Therapy in Orthopedics
Figure 13. Global Autologous Cell Therapy Market: Orthopedics (2020-2025) & ($ millions)
Figure 14. Autologous Cell Therapy in Cancer
Figure 15. Global Autologous Cell Therapy Market: Cancer (2020-2025) & ($ millions)
Figure 16. Autologous Cell Therapy in Wound Healing
Figure 17. Global Autologous Cell Therapy Market: Wound Healing (2020-2025) & ($ millions)
Figure 18. Autologous Cell Therapy in Others
Figure 19. Global Autologous Cell Therapy Market: Others (2020-2025) & ($ millions)
Figure 20. Global Autologous Cell Therapy Market Size Market Share by Application in 2024
Figure 21. Global Autologous Cell Therapy Revenue Market Share by Player in 2024
Figure 22. Global Autologous Cell Therapy Market Size Market Share by Region (2020-2025)
Figure 23. Americas Autologous Cell Therapy Market Size 2020-2025 ($ millions)
Figure 24. APAC Autologous Cell Therapy Market Size 2020-2025 ($ millions)
Figure 25. Europe Autologous Cell Therapy Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Autologous Cell Therapy Market Size 2020-2025 ($ millions)
Figure 27. Americas Autologous Cell Therapy Value Market Share by Country in 2024
Figure 28. United States Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Autologous Cell Therapy Market Size Market Share by Region in 2024
Figure 33. APAC Autologous Cell Therapy Market Size Market Share by Type (2020-2025)
Figure 34. APAC Autologous Cell Therapy Market Size Market Share by Application (2020-2025)
Figure 35. China Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. India Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Autologous Cell Therapy Market Size Market Share by Country in 2024
Figure 42. Europe Autologous Cell Therapy Market Size Market Share by Type (2020-2025)
Figure 43. Europe Autologous Cell Therapy Market Size Market Share by Application (2020-2025)
Figure 44. Germany Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. France Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Autologous Cell Therapy Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Autologous Cell Therapy Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Autologous Cell Therapy Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Autologous Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 58. APAC Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 59. Europe Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 61. United States Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 62. Canada Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 63. Mexico Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 64. Brazil Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 65. China Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 66. Japan Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 67. Korea Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 69. India Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 70. Australia Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 71. Germany Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 72. France Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 73. UK Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 74. Italy Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 75. Russia Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 76. Egypt Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 77. South Africa Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 78. Israel Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 79. Turkey Autologous Cell Therapy Market Size 2026-2031 ($ millions)
Figure 80. Global Autologous Cell Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Autologous Cell Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Autologous Cell Therapy Market Size 2026-2031 ($ millions)